Literature DB >> 7988435

Follicle-stimulating hormone increases the expression of tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 and induces TIMP-1 AP-1 site binding complex(es) in prepubertal rat Sertoli cells.

S Ulisse1, A R Farina, D Piersanti, A Tiberio, L Cappabianca, G D'Orazi, E A Jannini, O Malykh, W G Stetler-Stevenson, M D'Armiento.   

Abstract

Primary cultures of prepubertal rat Sertoli cells secrete two major tissue inhibitors of metalloproteinases: TIMP-1 (M(r) 28K) and TIMP-2 (M(r) 21 K). FSH stimulated Sertoli cell TIMP-1 and TIMP-2 activity in a time- and dose-dependent manner and also stimulated TIMP-1 and TIMP-2 protein and messenger RNA levels. These effects were mimicked by the cAMP analog, 8-bromo-cAMP, and the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine. The protein kinase C activating phorbol ester phorbol myristate acetate (TPA) stimulated TIMP-1 but not TIMP-2 activity and messenger RNA levels. Cycloheximide and actinomycin-D inhibited basal TIMP-1 and TIMP-2 activity and inhibited the ability of FSH, 8-bromo-cAMP, and TPA to stimulate TIMP activity. The protein kinase A (PKA) inhibitor AMP Rp isomer did not affect basal TIMP-1 and TIMP-2 activity or TPA-stimulated TIMP-1 activity. However, the PKA inhibitor markedly reduced FSH and 3-isobutyl-1-methylxanthine stimulation of TIMP-1 and TIMP-2 activity. FSH, 8-bromo-cAMP, and TPA stimuli induced DNA binding complexes capable of binding to a TIMP-1 AP-1 site consensus sequence oligonucleotide. The AP-1 site binding complex(es) induced by all three treatments reacted with antibodies directed broadly against fos and jun protooncogene families and against the specific family members c-fos, junB, and junD but not c-jun proteins. Constitutive cAMP response element binding activity capable of binding an artificial cAMP response element binding site oligonucleotide was demonstrated in Sertoli cell nuclear extracts. This activity was minimally modulated by FSH, 8-bromo-cAMP, or TPA treatment. In summary, Sertoli cells secrete TIMP-1 and TIMP-2 that can be coordinately up-regulated by FSH through a cAMP, PKA-dependent pathway. a convergence of TPA, FSH, and cAMP mediated signals in prepubertal Sertoli cells may occur with the induction of specific AP-1 site binding complex(es) containing jun and fos proteins. Our data suggest that FSH stimulation of TIMP-2 expression may be regulated independently to that of TIMP-1. We propose that the ability of FSH to stimulate Sertoli cell TIMP activity suggests a central role for this hormone in the control of extracellular matrix turnover during testicular development at the level of metalloproteinase inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988435     DOI: 10.1210/endo.135.6.7988435

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Transcriptional suppression of Sertoli cell Timp2 in rodents following mono-(2-ethylhexyl) phthalate exposure is regulated by CEBPA and MYC.

Authors:  Pei-Li Yao; Yi-Chen Lin; John H Richburg
Journal:  Biol Reprod       Date:  2011-08-10       Impact factor: 4.285

2.  Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility.

Authors:  L A Rudolph-Owen; P Cannon; L M Matrisian
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

3.  Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development.

Authors:  L Blavier; Y A DeClerck
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

4.  TNF alpha-mediated disruption of spermatogenesis in response to Sertoli cell injury in rodents is partially regulated by MMP2.

Authors:  Pei-Li Yao; Yi-Chen Lin; John H Richburg
Journal:  Biol Reprod       Date:  2008-11-26       Impact factor: 4.285

5.  Matrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasma.

Authors:  Ioannis Tentes; Byron Asimakopoulos; Efthimia Mourvati; Klaus Diedrich; Safaa Al-Hasani; Nikos Nikolettos
Journal:  J Assist Reprod Genet       Date:  2007-07-07       Impact factor: 3.412

6.  Novel insights into the downstream pathways and targets controlled by transcription factors CREM in the testis.

Authors:  Rok Kosir; Peter Juvan; Martina Perse; Tomaz Budefeld; Gregor Majdic; Martina Fink; Paolo Sassone-Corsi; Damjana Rozman
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 7.  Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders.

Authors:  Yoon-Seong Kim; Tong H Joh
Journal:  Biomol Ther (Seoul)       Date:  2012-03       Impact factor: 4.634

Review 8.  Patient with mutation in the matrix metalloproteinase 2 (MMP2) gene - a case report and review of the literature.

Authors:  Alka V Ekbote; Sumita Danda; Andreas Zankl; Kausik Mandal; Tina Maguire; Kobus Ungerer
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

9.  Semen levels of matrix metalloproteinase (MMP) and tissue inhibitor of metallorproteinases (TIMP) protein families members in men with high and low sperm DNA fragmentation.

Authors:  Larissa Berloffa Belardin; Mariana Pereira Antoniassi; Mariana Camargo; Paula Intasqui; Renato Fraietta; Ricardo Pimenta Bertolla
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

10.  Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) production.

Authors:  Patricia Langjahr; David Díaz-Jiménez; Marjorie De la Fuente; Estefhany Rubio; Douglas Golenbock; Francisca C Bronfman; Rodrigo Quera; María-Julieta González; Marcela A Hermoso
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.